[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-BMRN":3,"homepage-market-summary":31,"stock-news-BMRN":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"BMRN","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"BioMarin Pharmaceuticals Inc","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.","3,221","Novato, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},57.18,58.52,58.73,57.15,58.44,-1.26,-2.16,2191216.865125,31884,57.5581,70.98,49.26,2275541.3763759523,36.5,6839,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},20,[176,182,188,194,200,206,212,218,224,229,235,241,246,252,257,262,267,272,277,282],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"BioMarin Pharmaceutical Inc. (BMRN) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE5kN1RnQVEzRHZWSWpHUnVlbDZteHg1ZkYzLXZJRDlDbFo4X0g4YkZjVDFFdnEydjdMdDhaYWlxVUhXb2ZiOGdKdjVadEpNRV96Znc?oc=5","Sat, 03 Oct 2026 01:52:18 GMT","BioMarin Pharmaceutical Inc. (BMRN) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"BioMarin Pharmaceutical Inc. (BMRN) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTFBLUWZFRzNCenRHREgyNFlhQWNiVk5MY1gzX09kdTBlNmZnaF8wa3BQY0lrWFYxOE8wMVprVHRzd2JGNkhfOFNwSWJ4eS1pSWt4RFE?oc=5","Fri, 02 Oct 2026 10:14:13 GMT","BioMarin Pharmaceutical Inc. (BMRN) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"BMRN Stock Price Prediction 2026-2027 | BioMarin Forecast - 24\u002F7 Wall St.","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxQT0ZMTVhFQTd6QkhlajU4U0MzV0xIZzlMOFl4MzdUZlM1dGl0bWZEWFBlbmhsa1AtRmg2Mk5yNkI5WlZVTnItUVBrank0cmdJM3FXOHpkb1NreEg5clctM1cwMURLeGpSNzhaU0RaZzk3M2lITFliZE5TamdULXhTUldxMkZUUlA1RW1iSzlKdS0?oc=5","Fri, 02 Oct 2026 17:09:06 GMT","BMRN Stock Price Prediction 2026-2027 | BioMarin Forecast 24\u002F7 Wall St.","24\u002F7 Wall St.",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"After 4,086 shares were delivered or withheld, BioMarin (BMRN) R&D chief holds 47,732 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPSERuT2NOOEtRNXl0b2c1LTl0TUVjRERpcDR5MmVORVFlOE42eVA2WUZlQVpWdkJReDBESnFlVFZPU2NZcFBOSEtWTGE5cnJQVnlJYnFiMVdRX1BEcTZXcm0zM010YWs2VTBaR1I1d2I2N3FLbm12UVd2bkFrYkRra0JIMGo4UFYzLW9MOTlzVjY1YXBpeWpfeGNVcWhXVnY3SWUtWjc2R1o4aWxGSW5hTjB2MWJXcDFubWM5U3Jn?oc=5","Thu, 01 Oct 2026 20:23:35 GMT","After 4,086 shares were delivered or withheld, BioMarin (BMRN) R&D chief holds 47,732 shares. Stock Titan","Stock Titan",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"BioMarin: Why I See Significant Upside Into 2027 (NASDAQ:BMRN) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxOVXNPVjFrWE03WExKN2x0WElmMWVleGlzRXJnZEpVbUdGOVFqZEJFVFQ5MDFaYmp1dzBPV2ZTa1lUWFJhcjhkRWJkTzliSXJkMlZjWGFkcGh3cDRDWFpNWXY2Y29ESng0ai1zMDRfbkpvMFFEMW5LM28yaEIybklvMnBhQkpSRk1uOXhWc09qOHY5UQ?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","BioMarin: Why I See Significant Upside Into 2027 (NASDAQ:BMRN) Seeking Alpha","Seeking Alpha",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"3 Healthcare Stocks That Fall Short - StockStory","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxPQlpZZGVhMG5mVUFKeFVNRFBQYlhQVlFHVTJmVzJ2UmVwdmszOHoxbklzZzVtdUdwaWVHMVdTSFRrUGgyck1OQUhDeTNJclBLQWI4bl9SSmpqQVk3aWFGTDFtdjJSTHBraFIySXUtd0tEOHdOZzBWTVZvdW9tQ1hGVTZnUTNOZVJ3Uy1WakpjbF9xX3FhQ1RoWEFlOEJndw?oc=5","Mon, 28 Sep 2026 09:31:00 GMT","3 Healthcare Stocks That Fall Short StockStory","StockStory",{"title":213,"link":214,"pubDate":215,"description":216,"source":217},"BioMarin Pharmaceutical (BMRN) Adds Robert Plenge To Its Board - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7gFBVV95cUxNcDhzOGFSV0FwSUhiaThHMC03bkdad1lEcHY5MW1nemtvR3JTS2lZZEpXZDVCTUs2eTk2V1lHMW9lM2lvNTkwTzBfY1VfX1A3cUIycWtGWnZFMHpGTnRGcWVJZldfejA0M2VFX2p4b1RiUHowdlpwdVYtVFpYekhub013RzlHVUlUcDZ1cHpGZ2JQeGxSSXp4OWVsbW9ScE10M29hTEx0dzB1OTVMOHNLMkhtM3M5eVplRDBrNDNIOC1FT2ZjMHl4c3VjZk45RzV3bXJ6VzE3WFM0UzVaU2NfSHRzX0VPMHpFX0lLeUpB0gHzAUFVX3lxTFB0M09aVWI1T2xhZ3R4Tm52RzBHbUVybDYxUHlDcElCaTl0RGktVFRFc2JfTmhZZVRCMHZsT0tVMU00NV9yeXA2OGtTMjFKaUtQNDJPLVBIWllGSVZzSHNIWE50X0tBaTgycjU5emZ2MDNodV8xYkw0U2pfNkxGSkdCcE5MZGp1UFNaT1BQTkxTcEFPbERodllicVdzU0NzeUpId0Y4XzZXRkxXWWdZU0VXa0xxcm8xRWJ0MmxTYlJkZk0zbGRvYXE0YXJNOERpTVpxNUJiMUdMMlhBVWtSdFNvcDZJYmRPUGt1d0tLVE5qS01LVQ?oc=5","Sat, 26 Sep 2026 20:42:27 GMT","BioMarin Pharmaceutical (BMRN) Adds Robert Plenge To Its Board Simply Wall Street","Simply Wall Street",{"title":219,"link":220,"pubDate":221,"description":222,"source":223},"Discipline and Rules-Based Execution in BMRN Response - news.stocktradersdaily.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizgFBVV95cUxQMUR4U2YxVmlVNExFTC1sV2V4cTItN0hTeG1XdGRjY1NUV2VfNEZfSjBwc0wzNUxWbl94V0R6VXpEVk5fMHc3REg0bUFhV3JuT2c4YUo2NVd4cHFaaHNoVlJFOFJ1SGdRbUdrdDFrTWNNdE5SX3Y3T3BRLTY0TzFyZjAydENpU1pSaVlPRUY1VHNVaUYzNlVyNlRtcTJWTVEtTkZvM1FQYTZVeExfNUdmNEdZSXNaanBjRmR0UHZicUY3ZDFYNHgwZlNhdmlNdw?oc=5","Wed, 30 Sep 2026 12:48:01 GMT","Discipline and Rules-Based Execution in BMRN Response news.stocktradersdaily.com","news.stocktradersdaily.com",{"title":225,"link":226,"pubDate":227,"description":228,"source":217},"What BioMarin Pharmaceutical (BMRN)'s AI Drug Discovery Deal Means For Shareholders - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Fri, 02 Oct 2026 12:44:59 GMT","What BioMarin Pharmaceutical (BMRN)'s AI Drug Discovery Deal Means For Shareholders Simply Wall Street",{"title":230,"link":231,"pubDate":232,"description":233,"source":234},"BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxQZFpuWHRHekdDNlV4Ri1YT1dKWkVtOEhVNGp6LWwzZHJqaHZEbUFyaWluWUNsTlJFNV9QME11MDBPdVdvM1FBWWVPa2FCSkRLdWdDbXRZak5veFlVRHFtY1JldUk2YnVUUkhoeVBWUUVaMXMxcGNpMi04RGtQOGlDNGJkTzJ6c3p1dDkyS0lfZw?oc=5","Thu, 01 Oct 2026 08:02:47 GMT","BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts Yahoo Finance","Yahoo Finance",{"title":236,"link":237,"pubDate":238,"description":239,"source":240},"BioMarin Pharmaceutical stock holds near a $12.38 billion value - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxQTWdzZDlDTV9YMUNrOWpjR29wbm1ibmNsVmQ1b3pyV2pOR0RyN2NNb1kwRDh5UTdQeV9kVHJxTktnZW1DRGpVMm0yVXdpRG9iS0FoemE1WmxPNFRQQjFteHBlVnBTOWxpU2JreXR0c2oyeGVmREhWSGhkZXNOaWN4RzNuWjlYcExFOVQ3VVVKdG9DcGEwSFhyWF9ocldBUWlnYVpzd2QyUVZ0bmxPdDlGTVVVcTRKalpORm1uazZn?oc=5","Sun, 20 Sep 2026 19:17:05 GMT","BioMarin Pharmaceutical stock holds near a $12.38 billion value AD HOC NEWS","AD HOC NEWS",{"title":242,"link":243,"pubDate":244,"description":245,"source":217},"BioMarin Pharmaceutical (BMRN) Could Be 35% Undervalued Following Profluent AI Collaboration - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 01 Oct 2026 05:22:59 GMT","BioMarin Pharmaceutical (BMRN) Could Be 35% Undervalued Following Profluent AI Collaboration Simply Wall Street",{"title":247,"link":248,"pubDate":249,"description":250,"source":251},"BMRN Q2 2026 Earnings: EPS Beats Estimates by 4% but Shares Slip - Guidance Revision Trend - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4gFBVV95cUxPVy1kOWZvcnpnUmRJQmF5dE5ZekpHZHV3Tm1SZHJSUk12M1o3SEFBbk5CYTNDYkZLcjMzeUZMdFJac3F3b29TelVEWW1KRFR4U0J4M1Z0YmJvWnNhRDJoYXJYR280Vkh2RU5kelBhcEN4NHBpaGdfakI3Vkk4TFMteEFPNUVkaGdheDNBT3FvQ3NaM005YjJWemdCZnhfcVhwUXljSkVCMW9BZkdCVWRNeEI4NGRDa25mb3NCZDRyMUd2NDFSOEhIMkFObmtsRERnZlFZZXJxcUhfV3JkVzRURVd3?oc=5","Sun, 20 Sep 2026 17:31:00 GMT","BMRN Q2 2026 Earnings: EPS Beats Estimates by 4% but Shares Slip - Guidance Revision Trend dars.gov.et","dars.gov.et",{"title":253,"link":254,"pubDate":255,"description":256,"source":240},"BioMarin Pharmaceutical stock holds near its 52-week low - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitgFBVV95cUxQME5MVFZwSGtnQUpmNzNBbDBrRF9XTXJURFdPdlp0eC1PaWdrQl8wa1lpMkNla0c1RmhURUdid2VMVDF6SV9LMWg5Tk11Y1JGeHN1dmxLazlTbW9xdlJmekJXT1NUV3Zfb2dVWTVEWnQybVhtdmg5M2hiYkd1VWtIVjRKQ0RLcGo1aXlzNDNFNkY5ZjlEUXRSZFpoVzZSbUdzZ0g1Q3dBOWFiZjkzdnJtV1ZrTWZlZw?oc=5","Tue, 22 Sep 2026 21:06:50 GMT","BioMarin Pharmaceutical stock holds near its 52-week low AD HOC NEWS",{"title":258,"link":259,"pubDate":260,"description":261,"source":251},"BMRN Q2 2026 Earnings: EPS Beats Estimates by 4% but Shares Slip - Revenue Growth Report - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4gFBVV95cUxQd0pBSnRXYzFjNFhRajN6eUdrclhaUWt1YTRHcElEV3VZMEkwenRGWGxLRU5wejdOMENsZnpoNU0wTzNqVTF4UENVazJtODZsWWVvRVR3WTMwanNLZENHQmNtdzE4RDZFbVhCR1ZJRnNheVo5MmxUSHplaEc3djFVbTFSaHRWRTVUeFVBOFVGZXZtWlB2bE51eC1zVEZuRnhvZXQ3QXdxZk5vaWdETXc1bWhvTUlfU1NZcWtWVTlJQWxLcEFWNUJvcVdHZnlPUTluTHhqblBBUG1Mdko5Z3hZY3lB?oc=5","Sun, 20 Sep 2026 17:45:15 GMT","BMRN Q2 2026 Earnings: EPS Beats Estimates by 4% but Shares Slip - Revenue Growth Report dars.gov.et",{"title":263,"link":264,"pubDate":265,"description":266,"source":240},"BioMarin Pharmaceutical stock weighs VOXZOGO setback against growth - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxPLXRLUzdWanZ6ZzVGYkl4WVA1S3dXZHBscnhGbXg0U1hLQ0p2d0U3QkFMbFo3X0thUHU0dlFqRy00ZVkwZGpRbGo1NHNDclk4QzVmekJzdEZrNDllRVd2YmtMOXpjZE1ZejB6VUxraWE5NXdzUUQ4RU9RNElyQUFaMHlEUHRza05Mclhic0pQMDIwSGNUdWNablZYMy1sUFM2cjZQTE9UVzduUzNLZy1fTVFoV3puZ1FBczF1bnRkNUprYlFZ?oc=5","Wed, 30 Sep 2026 22:56:12 GMT","BioMarin Pharmaceutical stock weighs VOXZOGO setback against growth AD HOC NEWS",{"title":268,"link":269,"pubDate":270,"description":271,"source":240},"BioMarin Pharmaceutical stock falls 1.38 percent on Nasdaq - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxOMXVSUE1Dd2NuMUowOHBhc0xLbGNINF9lXzJGSGd0eGowVHo0UmdEdkVmM1RqSlNIczZZZmtwNmpFZ1FKTUExdngxMVJabjlFZ1NUSHhRRUJPNWttY1B0U1puZHdUTGFZeG1QSUY3VktsX2lxY2V5bUJ0dG9feTRHQi1RbnAwbjc1b1cwM0ZYVjV5U3BfaWpsY1RqZm9pZGhnOF9HMC03Sjc1X0JUcmVQb0Y2SmlVSDcy?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","BioMarin Pharmaceutical stock falls 1.38 percent on Nasdaq AD HOC NEWS",{"title":273,"link":274,"pubDate":275,"description":276,"source":240},"BioMarin Pharmaceutical stock holds at $63.94 as analysts stay bullish - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxNUDRHZF9xLWt3eHJUemtRbnRpYUtXUWtaYkJJWFlaakFMNUNFQVBzSjBUUTlzc19aSmRsajZqUjR3NEFWcXVENDdJV195MHZBVS1NN0dxMTVaRWw1eTN0U3VaSkhCV3JvSUhxNFVjVVJUZGJFazhmemlaMkdtSm9Kb2FvNzJPQXJSU0REdWZHdE51NzlRX0NORHRmdmd5Y2Jfc0JZeS1mOHJZZW9teWdQRWdVSXhRcVlrRExEMU01SnEwMGVPa3Jj?oc=5","Wed, 23 Sep 2026 10:14:40 GMT","BioMarin Pharmaceutical stock holds at $63.94 as analysts stay bullish AD HOC NEWS",{"title":278,"link":279,"pubDate":280,"description":281,"source":251},"BMRN Q2 2026 Earnings: EPS Tops Consensus by 4.05% as Shares Edge Higher - Preliminary Results - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7AFBVV95cUxQZlJZY0xKVXgyQXJDZGdWazJteGIxYkpKeEEtUGF0eVkzc01VYlIwTl9oSWlMTUdoZWRIVzdDc1E1Z1g1OEFMYzhka3pFUlF2c0JZT0o1TDBSdXRELVFCbEpEN1lIRWk2QjF1b2tyRUMyQmNZcE5hdzV1RTU1THgyZVdTdDBLZFo1d2ZUVTQ1bmxVRXFXbG11RV8xS0hrSERwWU93ZDYyQXk1Q0FHMTJxSGFoclBFN3dZZXVpdG9aTVF2aXFQek9saS1DZFJvSHBUVFBLT3ljVjBtZ1U0alEySjBBSVR6aGR6ODNaSQ?oc=5","Mon, 21 Sep 2026 14:40:02 GMT","BMRN Q2 2026 Earnings: EPS Tops Consensus by 4.05% as Shares Edge Higher - Preliminary Results dars.gov.et",{"title":283,"link":284,"pubDate":285,"description":286,"source":287},"BioMarin Grants Ascendis Global License, Secures Royalty Revenues - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxPNDQ1ZmNIT3BIamh2ZWZkUFhUZVc3NEI1TDNVM3NIT25OcVZaRXVwR3o5NUVfSVB3cFNJdWdQQ0MwNXpHMXpvaXk0dDRDTVU1dHJkaTczMWVaanpuYUlaZDZHMXhfNVlPdW9VbDV1c2hSMWpYSXhySE5lS3Y1UUtjeHVxX3BGcUhDOENEWWhxREtmVFdKQVUtSmhMRklPMnVkSE9RZHY3R092enl4dDhCMlVxdi1zYlk?oc=5","Wed, 30 Sep 2026 21:01:18 GMT","BioMarin Grants Ascendis Global License, Secures Royalty Revenues TipRanks","TipRanks"]